Belite Bio Inc ADR (BLTE : NASDAQ)
Common Stock
$154.45
USD
+7.11 (4.83%)
Last updated: 2026-10-20
Follow BLTE
BLTE
Belite Bio Inc ADR
WealthAwesomePerformance
1 Day
+4.83%
1 Week
+1.70%
1 Month
-9.66%
YTD
+4.12%
Key Statistics
Market Cap
$5.99B
52W High
$200.00
52W Low
$89.16
P/E Ratio
-
50 Day MA
$164.69
200 Day MA
$160.78
Beta
-1.23
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/20/2026 | $148.69 | $156.04 | $148.16 | $154.45 | $154.45 | 209,726 |
| 10/19/2026 | $143.46 | $150.47 | $142.94 | $147.34 | $147.34 | 148,873 |
| 10/16/2026 | $152.62 | $152.62 | $141.62 | $142.78 | $142.78 | 193,800 |
| 10/15/2026 | $153.87 | $155.47 | $152.13 | $152.62 | $152.62 | 195,856 |
| 10/14/2026 | $151.17 | $155.09 | $150.02 | $152.72 | $152.72 | 158,491 |
| 10/13/2026 | $157.01 | $161.00 | $150.93 | $151.87 | $151.87 | 233,364 |
| 10/12/2026 | $154.95 | $160.74 | $154.63 | $158.59 | $158.59 | 240,776 |
| 10/9/2026 | $152.73 | $155.99 | $152.17 | $154.49 | $154.49 | 179,300 |
| 10/8/2026 | $155.79 | $155.85 | $150.21 | $152.52 | $152.52 | 154,319 |
| 10/7/2026 | $155.09 | $156.75 | $154.60 | $156.08 | $156.08 | 97,801 |
Analyst Price Targets
Based on 9 analysts covering BLTE · as of Oct 5, 2026
Wall Street analysts forecast BLTE stock price to rise 48.2% over the next 12 months.
Consensus
Strong Buy4.78 / 5.00
Avg. Target
US$228.89
+48.2% Upside
Current Price
US$154.45
Last close
Analyst Breakdown (9 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLTE's historical volatility
30-Day Vol
41.4%
Annualized
90-Day Vol
49.7%
Annualized
Trend (90d)
-10.7%
Annualized drift
90d Mean
US$148.67
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$152.50 | US$132.22 – US$175.89 |
| 60 trading days | US$150.57 | US$123.05 – US$184.24 |
| 90 trading days | US$148.67 | US$116.11 – US$190.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Belite Bio Inc ADR
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-118.49M
- Profit Margin
- 0.00%
- ROE (TTM)
- -22.10%
- EPS (Diluted)
- -2.74
- Book Value
- 19.29
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About BLTE.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| ZVZZT | NASDAQ TEST STOCK | $25.25 | +83.24% |
| PRSO | Peraso Inc | $0.59 | +54.13% |
| ATGL | Alpha Technology Group Limited Ordinary Shares | $6.93 | +52.64% |
| BRZE | Braze Inc | $45.57 | +51.70% |
| NVNIF | Nvni Group Limited | $0.06 | +46.83% |
| AIXI | XIAO-I Corporation | $3.10 | +40.91% |
| LESLQ | Leslie's, Inc. | $0.04 | +38.75% |
| FRTT | Fort Technology Inc. | $0.71 | +32.63% |
BLTE.US news timeline
1 article covering BLTE.US, most recent first
Latest